{"transactions":[{"id":949874,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2026-01-05T17:10:55.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":2106505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":13096837,"derivative":{"exercise_price":3.42,"expiration_date":"2036-01-01","underlying":"Common Shares","underlying_shares":2106505},"source":{"system":"sec-edgar","filing":"0001834412-26-000002","document":"wk-form4_1767633053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441226000002/wk-form4_1767633053.xml","form_type":"4"}},{"id":1313306,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2025-01-03T20:36:28.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":2730109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date"}],"balance_after":10990332,"derivative":{"exercise_price":2.93,"expiration_date":"2035-01-01","underlying":"Common Shares","underlying_shares":2730109},"source":{"system":"sec-edgar","filing":"0001628280-25-000232","document":"wk-form4_1735936582.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025000232/wk-form4_1735936582.xml","form_type":"4"}},{"id":1350525,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2024-11-26T22:38:20.000Z","date":"2024-11-25","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8260223,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001628280-24-049327","document":"wk-form4_1732660694.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024049327/wk-form4_1732660694.xml","form_type":"4"}},{"id":1350524,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-11-26T22:38:20.000Z","date":"2024-11-25","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":898000,"source":{"system":"sec-edgar","filing":"0001628280-24-049327","document":"wk-form4_1732660694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024049327/wk-form4_1732660694.xml","form_type":"4"}},{"id":1399876,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2024-09-24T20:09:35.000Z","date":"2024-09-20","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8316348,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001628280-24-041217","document":"wk-form4_1727208568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024041217/wk-form4_1727208568.xml","form_type":"4"}},{"id":1399875,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-09-24T20:09:35.000Z","date":"2024-09-20","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":841875,"source":{"system":"sec-edgar","filing":"0001628280-24-041217","document":"wk-form4_1727208568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024041217/wk-form4_1727208568.xml","form_type":"4"}},{"id":1494743,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2024-06-03T20:21:18.000Z","date":"2024-05-31","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8372473,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001628280-24-026338","document":"wk-form4_1717446060.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024026338/wk-form4_1717446060.xml","form_type":"4"}},{"id":1494742,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-06-03T20:21:18.000Z","date":"2024-05-31","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":785750,"source":{"system":"sec-edgar","filing":"0001628280-24-026338","document":"wk-form4_1717446060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024026338/wk-form4_1717446060.xml","form_type":"4"}},{"id":1614506,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2024-02-27T19:12:58.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8428598,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001703057-24-000026","document":"wk-form4_1709061178.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000026/wk-form4_1709061178.xml","form_type":"4"}},{"id":1614505,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-02-27T19:12:58.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":729625,"source":{"system":"sec-edgar","filing":"0001703057-24-000026","document":"wk-form4_1709061178.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000026/wk-form4_1709061178.xml","form_type":"4"}},{"id":1678892,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2024-01-16T23:14:23.000Z","date":"2024-01-14","kind":"grant","planned":false,"acquired":true,"shares":2095532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8484723,"derivative":{"exercise_price":5.39,"expiration_date":"2034-01-14","underlying":"Common Shares","underlying_shares":2095532},"source":{"system":"sec-edgar","filing":"0001703057-24-000002","document":"wk-form4_1705446854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000002/wk-form4_1705446854.xml","form_type":"4"}},{"id":1729338,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2023-11-27T21:45:10.000Z","date":"2023-11-23","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6389191,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001703057-23-000044","document":"wk-form4_1701121501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000044/wk-form4_1701121501.xml","form_type":"4"}},{"id":1729337,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-11-27T21:45:10.000Z","date":"2023-11-23","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":673500,"source":{"system":"sec-edgar","filing":"0001703057-23-000044","document":"wk-form4_1701121501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000044/wk-form4_1701121501.xml","form_type":"4"}},{"id":1795986,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2023-08-25T17:57:14.000Z","date":"2023-08-24","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6445316,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001703057-23-000027","document":"wk-form4_1692986225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000027/wk-form4_1692986225.xml","form_type":"4"}},{"id":1795985,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-08-25T17:57:14.000Z","date":"2023-08-24","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":617375,"source":{"system":"sec-edgar","filing":"0001703057-23-000027","document":"wk-form4_1692986225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000027/wk-form4_1692986225.xml","form_type":"4"}},{"id":1874221,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2023-05-30T17:14:36.000Z","date":"2023-05-26","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6501441,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-23-032793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123032793/doc4.xml","form_type":"4"}},{"id":1874220,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-05-30T17:14:36.000Z","date":"2023-05-26","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":561250,"source":{"system":"sec-edgar","filing":"0001209191-23-032793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123032793/doc4.xml","form_type":"4"}},{"id":1995198,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2023-02-23T21:33:24.000Z","date":"2023-02-22","kind":"exercise","acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6557566,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-23-012199","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123012199/doc4.xml","form_type":"4"}},{"id":1995197,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-02-23T21:33:24.000Z","date":"2023-02-22","kind":"exercise","acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":505125,"source":{"system":"sec-edgar","filing":"0001209191-23-012199","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123012199/doc4.xml","form_type":"4"}},{"id":2095493,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options (right to buy)","published_at":"2022-12-05T17:13:30.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":925069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6613691,"derivative":{"exercise_price":13.18,"expiration_date":"2032-12-01","underlying":"Common Shares","underlying_shares":925069},"source":{"system":"sec-edgar","filing":"0001209191-22-059566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122059566/doc4.xml","form_type":"4"}},{"id":2108173,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2022-11-22T02:36:15.000Z","date":"2022-11-18","kind":"exercise","acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5688622,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-22-058300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122058300/doc4.xml","form_type":"4"}},{"id":2108172,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-11-22T02:36:15.000Z","date":"2022-11-18","kind":"exercise","acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":449000,"source":{"system":"sec-edgar","filing":"0001209191-22-058300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122058300/doc4.xml","form_type":"4"}},{"id":2176671,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2022-08-22T19:09:12.000Z","date":"2022-08-18","kind":"exercise","acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5744747,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-22-046995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122046995/doc4.xml","form_type":"4"}},{"id":2176670,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-08-22T19:09:12.000Z","date":"2022-08-18","kind":"exercise","acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":392875,"source":{"system":"sec-edgar","filing":"0001209191-22-046995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122046995/doc4.xml","form_type":"4"}},{"id":2263071,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2022-05-19T17:17:38.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5800872,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-22-030394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122030394/doc4.xml","form_type":"4"}},{"id":2263070,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-05-19T17:17:38.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":336750,"source":{"system":"sec-edgar","filing":"0001209191-22-030394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122030394/doc4.xml","form_type":"4"}},{"id":2371374,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2022-02-25T18:50:48.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5856997,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-22-013012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122013012/doc4.xml","form_type":"4"}},{"id":2371373,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-02-25T18:50:48.000Z","date":"2022-02-22","kind":"exercise","acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":280625,"source":{"system":"sec-edgar","filing":"0001209191-22-013012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122013012/doc4.xml","form_type":"4"}},{"id":2412815,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-02-03T23:56:51.000Z","date":"2021-12-07","kind":"gift","acquired":false,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"This transaction represents a charitable donation of 750,000 common shares donated by Thermopylae Holdings Ltd. on December 7, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person."}],"balance_after":53807290,"source":{"system":"sec-edgar","filing":"0001209191-22-006963","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122006963/doc5.xml","form_type":"5"}},{"id":2412814,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-02-03T23:56:51.000Z","date":"2021-05-24","kind":"gift","acquired":false,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction represents a charitable donation of 1,250,000 common shares donated by Thermopylae Holdings Ltd. on May 24, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person."}],"balance_after":54557290,"source":{"system":"sec-edgar","filing":"0001209191-22-006963","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122006963/doc5.xml","form_type":"5"}},{"id":2412813,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-02-03T23:56:51.000Z","date":"2021-05-24","kind":"gift","acquired":false,"shares":223500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents a charitable donation of 223,500 common shares donated by Hankla Family Trust (2019) on May 24, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Due to clerical error, the number of shares held by Hankla Family Trust (2019) was overstated by 10,000 shares on the reporting person's prior Form 4 filings."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Hankla Family Trust (2019), of which the reporting person and his spouse are joint trustees. The reporting person disclaims beneficial\nownership of such securities, except to the extent of his indirect pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-006963","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122006963/doc5.xml","form_type":"5"}},{"id":2478521,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-12-09T23:00:45.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":920312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 7, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date"}],"balance_after":5913122,"derivative":{"exercise_price":14.55,"expiration_date":"2031-12-07","underlying":"Common Shares","underlying_shares":920312},"source":{"system":"sec-edgar","filing":"0001209191-21-068850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121068850/doc4.xml","form_type":"4"}},{"id":2500004,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2021-11-22T22:03:00.000Z","date":"2021-11-18","kind":"exercise","acquired":false,"shares":224500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date"}],"balance_after":4992810,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":224500},"source":{"system":"sec-edgar","filing":"0001209191-21-066133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121066133/doc4.xml","form_type":"4"}},{"id":2500003,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2021-11-22T22:03:00.000Z","date":"2021-11-18","kind":"exercise","acquired":true,"shares":224500,"price":15.03,"value":3374235.0,"ownership":{"direct":true},"balance_after":224500,"source":{"system":"sec-edgar","filing":"0001209191-21-066133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121066133/doc4.xml","form_type":"4"}},{"id":2673268,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2021-06-10T21:11:35.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":401580,"price":25.5,"value":10240290.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"shares","element":"transactionShares","label":"F3","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by Hankla Family Trust (2019), of which the Reporting Person and his spouse are joint trustees. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein."}],"balance_after":233500,"source":{"system":"sec-edgar","filing":"0000899243-21-022993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022993/doc4.xml","form_type":"4"}},{"id":2673267,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2021-06-10T21:11:35.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":5598420,"price":24.03,"value":134530032.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $24.03."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $24.03."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $24.03."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the Reporting Person."}],"balance_after":55604330,"source":{"system":"sec-edgar","filing":"0000899243-21-022993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000089924321022993/doc4.xml","form_type":"4"}}]}